New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) </ ...

Americans who took proton pump inhibitors, or PPIs, for four-and-a-half years or longer were 33% more likely to develop ...

After adjusting for factors such as age, sex and race, as well as health-related issues such as high blood pressure and ...

The study found people who used proton pump inhibitors for more than 4.4 years were 33% more likely to be diagnosed with the ...

Neurologists have discovered that a common household drug, which has been previously linked to higher risk of stroke, broken ...

Regularly taking this tablet could increase the risk of developing the degenerative disease by as much as a third.

Gastroesophageal reflux disease (GERD), also known as gastro oesophageal reflux disease, is more than just the occasional ...

Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in ...

Braintree Laboratories, a part of Sebela Pharmaceuticals® and a leading manufacturer of gastroenterology pharmaceutical products, today announced positive topline results from two pivotal US Phase 3 ...

Proton pump inhibitors (PPIs) are among the most widely used medications in the U.S., familiar to many through brand names ...